BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scarth JP, Seibert C, Brown PR, Teale P, Beamon GJ, Pearce CM, Sams RA. UPLC-MS/MS Method for the Identification of Recombinant Human Erythropoietin Analogues in Horse Plasma and Urine. Chromatographia 2011;74:593-608. [DOI: 10.1007/s10337-011-2119-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Rodriguez-aller M, Gurny R, Veuthey J, Guillarme D. Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applications. Journal of Chromatography A 2013;1292:2-18. [DOI: 10.1016/j.chroma.2012.09.061] [Cited by in Crossref: 110] [Cited by in F6Publishing: 87] [Article Influence: 12.2] [Reference Citation Analysis]
2 Timms M, Steel R, Vine J. Identification of recombinant human EPO variants in greyhound plasma and urine by ELISA, LC-MS/MS and western blotting: a comparative study: EPO testing in greyhounds by ELISA, LC-MS/MS and western blotting. Drug Test Analysis 2016;8:164-76. [DOI: 10.1002/dta.1835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cavalcanti RTC, Teixeira PAC, Levy RS, Pereira HMG, Aquino Neto FR. Detection of ESAs in equine urine and blood by SAR‐PAGE. Drug Test Anal 2019;11:772-81. [DOI: 10.1002/dta.2569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Bailly-chouriberry L, Cormant F, Garcia P, Kind A, Popot M, Bonnaire Y. Identification of α- Cobratoxin in Equine Plasma by LC-MS/MS for Doping Control. Anal Chem 2013;85:5219-25. [DOI: 10.1021/ac4006342] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
5 Joré C, Loup B, Garcia P, Paris A, Popot M, Audran M, Bonnaire Y, Varlet-marie E, Bailly-chouriberry L. Liquid chromatography – high resolution mass spectrometry-based metabolomic approach for the detection of Continuous Erythropoiesis Receptor Activator effects in horse doping control. Journal of Chromatography A 2017;1521:90-9. [DOI: 10.1016/j.chroma.2017.09.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
6 Timms M, Steel R. Defining the specificity of recombinant human erythropoietin confirmation in equine samples by liquid chromatography-tandem mass spectrometry. Drug Test Anal 2021. [PMID: 34898016 DOI: 10.1002/dta.3210] [Reference Citation Analysis]
7 Delcourt V, Garcia P, Chabot B, Loup B, Remy P, Popot MA, Bailly-Chouriberry L. Screening and confirmatory analysis of recombinant human erythropoietin for racing camels' doping control. Drug Test Anal 2020;12:763-70. [PMID: 31984676 DOI: 10.1002/dta.2772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Selbes YS, Caglayan MG, Eryilmaz M, Boyaci IH, Saglam N, Basaran AA, Tamer U. Surface-enhanced Raman probe for rapid nanoextraction and detection of erythropoietin in urine. Anal Bioanal Chem 2016;408:8447-56. [DOI: 10.1007/s00216-016-9966-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
9 Lönnberg M, Bondesson U, Cormant F, Garcia P, Bonnaire Y, Carlsson J, Popot M, Rollborn N, Råsbo K, Bailly-chouriberry L. Detection of recombinant human EPO administered to horses using MAIIA lateral flow isoform test. Anal Bioanal Chem 2012;403:1619-28. [DOI: 10.1007/s00216-012-5972-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]